What is Burt's Pharmacy?
Operating for over four decades, Burt's Pharmacy and Compounding Lab has established itself as a cornerstone of health services in Newbury Park, Thousand Oaks, Moorpark, and Westlake Village. The firm distinguishes itself through a highly specialized focus on compounded medications, including bio-identical hormone replacement and pediatric-specific formulations. Beyond its pharmaceutical expertise, the company maintains a robust portfolio of home medical equipment and prescription delivery services. By prioritizing personalized patient care, the pharmacy has successfully navigated the complexities of the local healthcare market, transitioning from a traditional retail model to a sophisticated provider of customized therapeutic solutions.
How much funding has Burt's Pharmacy raised?
Burt's Pharmacy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Burt's Pharmacy
PPP
Public-Private Partnership
What's next for Burt's Pharmacy?
With this late-stage financing secured, Burt's Pharmacy is well-positioned to scale its compounding operations and modernize its supply chain logistics. The strategic allocation of this capital will likely focus on enhancing the technological integration of its prescription delivery services and expanding the reach of its specialized pain management and hormone replacement programs. As the healthcare landscape shifts toward more personalized, patient-centric models, the firm is poised to leverage its deep institutional knowledge and established regional presence to capture additional market share. Future growth will likely be driven by operational efficiencies and the continued expansion of its home medical supply offerings, ensuring the company remains a vital resource for its diverse client base.
See full Burt's Pharmacy company page
